Y Intercept Hong Kong Ltd Invests $2.69 Million in Colgate-Palmolive (NYSE:CL)

Y Intercept Hong Kong Ltd purchased a new position in Colgate-Palmolive (NYSE:CL - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 25,943 shares of the company's stock, valued at approximately $2,693,000.

Several other large investors have also modified their holdings of the stock. RFG Advisory LLC increased its holdings in shares of Colgate-Palmolive by 2.1% during the second quarter. RFG Advisory LLC now owns 5,411 shares of the company's stock valued at $525,000 after purchasing an additional 112 shares during the period. Sequoia Financial Advisors LLC grew its position in Colgate-Palmolive by 3.9% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 20,279 shares of the company's stock worth $1,968,000 after purchasing an additional 767 shares in the last quarter. Wedmont Private Capital lifted its holdings in shares of Colgate-Palmolive by 17.4% in the second quarter. Wedmont Private Capital now owns 6,943 shares of the company's stock valued at $681,000 after purchasing an additional 1,027 shares in the last quarter. M&G Plc grew its holdings in shares of Colgate-Palmolive by 88.8% during the second quarter. M&G Plc now owns 79,975 shares of the company's stock valued at $7,758,000 after buying an additional 37,616 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in Colgate-Palmolive by 6.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 218,937 shares of the company's stock valued at $21,246,000 after buying an additional 12,988 shares during the period. Institutional investors own 80.41% of the company's stock.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. TD Cowen lowered their price target on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research note on Monday, October 28th. UBS Group raised their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Colgate-Palmolive Price Performance

CL traded up $0.94 during midday trading on Tuesday, reaching $93.88. 4,324,841 shares of the company's stock were exchanged, compared to its average volume of 4,385,220. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business has a 50-day simple moving average of $96.33 and a two-hundred day simple moving average of $98.65. The firm has a market capitalization of $76.70 billion, a price-to-earnings ratio of 26.90, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.13%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.